- Pranosin syrup 50mg / ml is a medicine containing inosine pranobex. This substance acts antiviral and immunostimulating. The indications for use are immunocompromised states and recurrent infections of the upper respiratory tract.
active substance - inosine pranobex (a complex containing inosine, and 4-2-acetamidobenzoesan hydroksypropylodimetyloamoniowy at a molar ratio of 1: 3). 1 ml of syrup contains 50 mg of inosine Pranobex. Auxiliary components: sucrose, methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), sodium citrate (E331), sodium hydroxide (to adjust pH), raspberry aroma (comprising: flavorings, propylene glycol, lactic acid, acetic acid, ethanol, water, ascorbic acid), purified water.
The effect Pranosin is based on the properties of the substance contained in it active - inosine pranobeksie. It exhibits antiviral activity and stimulating the immune system functioning, which leads to an increase in resistance.
The drug Pranosin syrup 50mg / mL indicated for supporting people with impaired immune who constantly repent upper respiratory tract infection.
This product contains sucrose. Be sure to tell your doctor or pharmacist about all the medicines you are taking (especially if they are: allopurinol, increase the excretion of uric acid, also diuretics, zidovudine, medicines affecting the immune system). Please consult taking with your doctor if you are pregnant or breastfeeding. Keep out of reach of children, at room temperature.
Do not use in case of hypersensitivity to the active substance or other excipients contained in the drug. Contraindication is currently occurring gout, as well as increased levels of uric acid in the blood (shown in the study). Do not use less than 1 year old.
In case of side effects such as difficulty breathing, swelling of the face, eyelids, lips, rash, itching, sudden onset of wheezing should immediately consult a doctor. Other side effects: Very common: increased levels of uric acid in the urine or blood; common: increasing the level of urea in the blood, increased liver enzymes, itching, rash, joint pain, nausea and vomiting, epigastric discomfort, fatigue and tiredness, weakness, headaches and dizziness; Uncommon: constipation, diarrhea, nervousness, drowsiness, difficulty sleeping, polyuria;Not known: abdominal pain, angioedema, allergic reaction, anaphylactic reaction, urticaria, dizziness, erythema.
For oral use. Take as directed by your doctor or as described in the leaflet. The dose is determined on the basis of body weight and severity of the disease. The daily dose should be taken in equal doses administered several times a day. Adults, elderly: daily dose - 50 mg Inosine Pranobex per kilogram of body weight, or 1 ml of syrup per 1 kg of body weight per day. This means 3g daily Inosine Pranobex (60ml) was administered in 3-4 divided doses. The maximum daily dose of 4g inosine Pranobex (80ml syrup). Children over 1 year of age: daily dose - 50 mg Inosine Pranobex (1 ml of syrup) per kilogram of body weight given in 3-4 equally divided doses. The table facilitates dosage is on the leaflet. Package attached scoop dosing. Treatment should be continued for 5-14 days, if at this time there is no improvement or symptoms worsen, you should consult your doctor.